Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants by Stopfer, Lauren E, Gajadhar, Aaron S, Patel, Bhavin, Gallien, Sebastien, Frederick, Dennie T, Boland, Genevieve M, Sullivan, Ryan J, White, Forest M

Get full text

Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome by Shi, Alvin, Kasumova, Gyulnara G, Michaud, William A, Cintolo-Gonzalez, Jessica, Díaz-Martínez, Marta, Ohmura, Jacqueline, Mehta, Arnav, Chien, Isabel, Frederick, Dennie T, Cohen, Sonia, Plana, Deborah, Johnson, Douglas, Flaherty, Keith T, Sullivan, Ryan J, Kellis, Manolis, Boland, Genevieve M

Get full text

Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome by Shi, Alvin, Kasumova, Gyulnara G, Michaud, William A, Cintolo-Gonzalez, Jessica, Díaz-Martínez, Marta, Ohmura, Jacqueline, Mehta, Arnav, Chien, Isabel, Frederick, Dennie T, Cohen, Sonia, Plana, Deborah, Johnson, Douglas, Flaherty, Keith T, Sullivan, Ryan J, Kellis, Manolis, Boland, Genevieve M

Get full text

Targeting the cyclin-dependent kinase 5 in metastatic melanoma by Sharma, Samanta, Zhang, Tian, Michowski, Wojciech, Rebecca, Vito W, Xiao, Min, Ferretti, Roberta, Suski, Jan M, Bronson, Roderick T, Paulo, Joao A, Frederick, Dennie, Fassl, Anne, Boland, Genevieve M, Geng, Yan, Lees, Jacqueline A, Medema, Rene H, Herlyn, Meenhard, Gygi, Steven P, Sicinski, Piotr

Get full text

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition by Anderson, Daniel Griffith, Haq, Rizwan, Yokoyama, Satoru, Hawryluk, Elena B., Jonsson, Goran B., Frederick, Dennie Tompers, McHenry, Kevin, Porter, Dale, Tran, Thanh-Nga, Garraway, Levi A., Duncan, Lyn McDivitt, Morton, Donald L., Hoon, Dave S. B., Wargo, Jennifer A., Song, Jun S., Fisher, David E., Love, Kevin T, Langer, Robert S

Get full text
Get full text
Get full text

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine by Geller, Leore T., Barzily-Rokni, Michal, Danino, Tal, Jonas, Oliver H., Shental, Noam, Nejman, Deborah, Gavert, Nancy, Zwang, Yaara, Cooper, Zachary A., Shee, Kevin, Thaiss, Christoph A., Reuben, Alexandre, Livny, Jonathan, Avraham, Roi, Frederick, Dennie T., Ligorio, Matteo, Chatman, Kelly, Johnston, Stephen E., Mosher, Carrie M., Brandis, Alexander, Fuks, Garold, Gurbatri, Candice, Gopalakrishnan, Vancheswaran, Kim, Michael, Hurd, Mark W., Katz, Matthew, Fleming, Jason, Maitra, Anirban, Smith, David A., Skalak, Matthew T., Bu, Jeffrey, Michaud, Monia, Trauger, Sunia A., Barshack, Iris, Golan, Talia, Sandbank, Judith, Flaherty, Keith T., Mandinova, Anna, Garrett, Wendy S., Thayer, Sarah P., Ferrone, Cristina R., Huttenhower, Curtis, Bhatia, Sangeeta N., Gevers, Dirk, Wargo, Jennifer A., Golub, Todd R., Straussman, Ravid

Get full text

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade by Jerby-Arnon, Livnat, Shah, Parin, Cuoco, Michael S., Rodman, Christopher, Su, Mei-Ju, Melms, Johannes C., Leeson, Rachel, Kanodia, Abhay, Mei, Shaolin, Lin, Jia-Ren, Wang, Shu, Rabasha, Bokang, Liu, David, Zhang, Gao, Margolais, Claire, Ashenberg, Orr, Ott, Patrick A., Buchbinder, Elizabeth I., Haq, Rizwan, Hodi, F. Stephen, Boland, Genevieve M., Sullivan, Ryan J., Frederick, Dennie T., Miao, Benchun, Moll, Tabea, Flaherty, Keith T., Herlyn, Meenhard, Jenkins, Russell W., Thummalapalli, Rohit, Kowalczyk, Monika S., Cañadas, Israel, Schilling, Bastian, Cartwright, Adam N.R., Luoma, Adrienne M., Malu, Shruti, Hwu, Patrick, Bernatchez, Chantale, Forget, Marie-Andrée, Barbie, David A., Shalek, Alex K., Tirosh, Itay, Sorger, Peter K., Wucherpfennig, Kai, Van Allen, Eliezer M., Schadendorf, Dirk, Johnson, Bruce E., Rotem, Asaf, Rozenblatt-Rosen, Orit, Garraway, Levi A., Yoon, Charles H., Izar, Benjamin, Regev, Aviv

Get full text